CADIAN CAPITAL MANAGEMENT, LP
13F Reported Value
ⓘ$821.2M
Holdings
23
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
CADIAN CAPITAL MANAGEMENT, LP disclosed 23 positions worth $821.2M in its Form 13F-HR for Q1 2026, led by $IQV (IQVIA HOLDINGS INC.) at 16.9% of the equity portfolio, followed by $DKNG and $FLYW. During the quarter the fund opened 5 new positions and exited 8 — including a new stake in $PANW and a full exit from $VRNS. The portfolio is most concentrated in Healthcare (38.9% of disclosed assets). All figures are sourced directly from CADIAN CAPITAL MANAGEMENT, LP’s Form 13F-HR filing with the SEC under CIK 1423686.
AI Fund Analysis
ConcentratingSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 59.7#910
Quality
$138.7M813,152 sh - 54.0#1,242
Quality
$79.2M3,662,983 sh - 56.2#1,120
Quality
$77.0M6,618,119 sh - 36.1
Quality
$72.0M779,648 sh - 72.3
Quality
$69.6M832,700 sh - 66.5
Quality
$44.0M274,500 sh - 59.7
Quality
$39.5M4,776,343 sh - —
Quality
$37.3M539,610 sh - 68.8
Quality
$32.3M850,000 sh - 47.5
Quality
$32.1M1,248,372 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 IQVIA HOLDINGS INC.$IQV | 59.7#910 | $138.7M | 813,152 |
 DraftKings Inc.$DKNG | 54.0#1,242 | $79.2M | 3,662,983 |
 Flywire Corp$FLYW | 56.2#1,120 | $77.0M | 6,618,119 |
 Guardant Health, Inc.$GH | 36.1 | $72.0M | 779,648 |
 HEALTHEQUITY, INC.$HQY | 72.3 | $69.6M | 832,700 |
 Palo Alto Networks Inc$PANW | 66.5 | $44.0M | 274,500 |
 Cryoport, Inc.$CYRX | 59.7 | $39.5M | 4,776,343 |
 monday.com Ltd.$MNDY | — | $37.3M | 539,610 |
 Nutanix, Inc.$NTNX | 68.8 | $32.3M | 850,000 |
 Intapp, Inc.$INTA | 47.5 | $32.1M | 1,248,372 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of CADIAN CAPITAL MANAGEMENT, LP's 23 positions.
Showing top 10 of 23 holdings.
Sector Allocation
Healthcare
$319.7M
Technology
$249.3M
Industrials
$146.6M
Communication Services
$105.6M
Full Holdings — CADIAN CAPITAL MANAGEMENT, LP (Q1 2026)
All 23 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $IQV | IQVIA HOLDINGS INC. | $138.7M | 16.9% | +48% | 59.7 |
| 2 | $DKNG | DraftKings Inc. | $79.2M | 9.6% | -34% | 54 |
| 3 | $FLYW | Flywire Corp | $77.0M | 9.4% | -17% | 56.2 |
| 4 | $GH | Guardant Health, Inc. | $72.0M | 8.8% | -15% | 36.1 |
| 5 | $HQY | HEALTHEQUITY, INC. | $69.6M | 8.5% | +47% | 72.3 |
| 6 | $PANW | Palo Alto Networks Inc | $44.0M | 5.4% | NEW | 66.5 |
| 7 | $CYRX | Cryoport, Inc. | $39.5M | 4.8% | -4% | 59.7 |
| 8 | $MNDY | monday.com Ltd. | $37.3M | 4.5% | +23% | — |
| 9 | $NTNX | Nutanix, Inc. | $32.3M | 3.9% | -38% | 68.8 |
| 10 | $INTA | Intapp, Inc. | $32.1M | 3.9% | +575% | 47.5 |
| 11 |  $TCMD | TACTILE SYSTEMS TECHNOLOGY INC | $27.2M | 3.3% | -4% | 45.3 |
| 12 |  $PLNT | Planet Fitness, Inc. | $26.4M | 3.2% | NEW | 69.2 |
| 13 |  $EVH | Evolent Health, Inc. | $24.7M | 3.0% | -2% | 31.5 |
| 14 |  $SIBN | SI-BONE, Inc. | $23.8M | 2.9% | +61% | 37.7 |
| 15 |  $ALKT | ALKAMI TECHNOLOGY, INC. | $20.9M | 2.5% | +14% | 46.1 |
| 16 |  $PCOR | PROCORE TECHNOLOGIES, INC. | $18.8M | 2.3% | -69% | 51.8 |
| 17 |  $TSM | TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | $16.1M | 2.0% | -16% | — |
| 18 |  $VRSN | VERISIGN INC/CA | $11.2M | 1.4% | NEW | 71.6 |
| 19 |  $BSX | BOSTON SCIENTIFIC CORP | $10.7M | 1.3% | NEW | 79.9 |
| 20 |  $GLBE | Global-E Online Ltd. | $6.8M | 0.8% | -95% | — |
| 21 |  $OABI | OmniAb, Inc. | $6.5M | 0.8% | -6% | 9.7 |
| 22 |  $PEGA | PEGASYSTEMS INC | $5.1M | 0.6% | NEW | 69.6 |
| 23 |  $MXCT | MAXCYTE, INC. | $1.2M | 0.1% | -53% | 16.7 |
New Positions (5)
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for CADIAN CAPITAL MANAGEMENT, LP including:
Track CADIAN CAPITAL MANAGEMENT, LP's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for CADIAN CAPITAL MANAGEMENT, LP and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: CADIAN CAPITAL MANAGEMENT, LP
13F Pro is an AI hedge fund tracker and stock research platform. For CADIAN CAPITAL MANAGEMENT, LP (SEC CIK: 1423686), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in CADIAN CAPITAL MANAGEMENT, LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.